Document Detail


Associations between Drug Burden Index and Mortality in Older People in Residential Aged Care Facilities.
MedLine Citation:
PMID:  22276959     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Background: The Drug Burden Index (DBI), a measure of an individual's exposure to anticholinergic and sedative medications, is associated with functional impairment in community-dwelling, older people. In people from residential aged care facilities (RACFs), DBI score does not appear to be associated with functional impairment, but is associated with an increased risk of falls. Objective: We investigated the associations between increasing DBI score and mortality in older adults living in RACFs. Methods: Study participants (n = 602; 70.9% female), recruited from 51 RACFs in Sydney, Australia, had a mean ± standard deviation (SD) age of 85.7 ± 6.4 years and a mean ± SD DBI score of 0.58 ± 0.64. Results: Exposure to anticholinergic medication was 33.6% and sedative medications 41.9%. All-cause mortality after a variable follow-up time (774-1269 days) was 36.2% (n = 218), with the leading causes of death classified as stroke (n = 46; 21.1%), ischaemic heart disease/cardiovascular system (n = 44; 20.2%) and pneumonia (n = 31; 14.2%). One-year mortality multivariate models showed that the DBI categories low (n = 260; hazard ratio [HR] 1.13; 95% CI 0.82, 1.57) and high (n = 153; HR 1.19; 95% CI 0.82, 1.74) were not associated with mortality. This lack of a significant association remained after dichotomization into the anticholinergic and sedative components of the DBI. Conclusions: We found that with high exposure to anticholinergic and sedative medications, there was no significant association between increasing DBI score and all-cause mortality in old individuals living in RACFs. Further research into the adverse effects of medication use on the mortality of institutionalized older individuals is needed.
Authors:
Nicholas M Wilson; Sarah N Hilmer; Lyn M March; Jian Sheng Chen; Danijela Gnjidic; Rebecca S Mason; Ian D Cameron; Philip N Sambrook
Related Documents :
22722919 - Adherence to chronic disease medications among new york city medicaid participants.
22845339 - How does use of a prescription monitoring program change medical practice?
22761079 - Maximizing medication therapy management services through a referral initiative.
18360349 - The kappa lambda society of hippocrates: historical perspective on an early medical pro...
22759989 - Helicopter emergency medical service registrars do not comprehensively document primary...
22626049 - Ethnic disparities in undergraduate pre-clinical and clinical performance.
16940729 - Endoscopic therapy for gastroesophageal reflux disease: a systematic review.
10130909 - Robotic automation of medication-use management.
1256109 - Continuing education activities of physicians in solo and group practice: report on a p...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Drugs & aging     Volume:  29     ISSN:  1170-229X     ISO Abbreviation:  Drugs Aging     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-01-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9102074     Medline TA:  Drugs Aging     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  157-65     Citation Subset:  IM    
Affiliation:
Kolling Institute of Medical Research, Institute of Bone and Joint Research, Royal North Shore Hospital, Sydney, NSW, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Long-term safety, tolerability and efficacy of fesoterodine in subjects with overactive bladder symp...
Next Document:  Physician experience and rates of plasma HIV-1 RNA suppression among illicit drug users: an observat...